US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.607
  • -0.019-2.96%
Trading Mar 18 13:11 ET
51.60MMarket Cap-0.33P/E (TTM)

Century Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Century Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 475.000K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 475.000K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--

Unlock Free Earnings Estimates

Century Therapeutics Earnings Reports

  • Century Therapeutics | 8-K: Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 5, 2024 09:11 ET

  • Century Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 09:11 ET

  • Century Therapeutics | 8-K: Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 8, 2024 07:39 ET

  • Century Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 07:34 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Dorian LPG
    LPG
    +1.53%
    Lantheus
    LNTH
    +0.67%
    YETI Holdings
    YETI
    +0.41%
    Teradata Corp
    TDC
    +0.34%
    Workday
    WDAY
    +0.29%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 18, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data